from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1654/argB

LFCtreatmentdescriptionclass of inhibitor

-1.847

Amikacinug/mL Amikacintranslation

-1.882

Cap5-10ug/mL Capreomycintranslation

-1.412

Rox10-50 ug/mL Roxithromycintranslation

-0.734

SM2-5 ug/mL Streptomycintranslation

-3.243

Tet5-10 ug/mL Tetracyclinetranslation

-0.261

Rif0.2-5ug/mL Rifampicintranscription

0.077

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.178

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.496

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.147

CPZ10-50 ug/mL Chlorpromazinerespiration

0.480

Clofazimine10-13 ug/mL Clofaziminerespiration

0.150

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.074

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.196

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.421

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.282

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.147

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.348

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.319

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.653

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.484

KCN5-20 ug/mL Potassium cyaniderespiration

1.572

NaN30.2-2 mM Sodium aziderespiration

0.288

Nigericin50 uM Nigericinrespiration

-0.404

TRC10-150 ug/mL Triclosanrespiration

-0.436

TRZ10-25 ug/mL Thioridazinerespiration

0.914

Valinomycin0.5-10 uM Valinomycinrespiration

-0.152

ZnSO42 mM ZnSO4respiration

0.295

menadione6-10 ug/mL Menadionerespiration

0.318

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.081

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.016

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.356

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.487

NRP_1Non-replicating persistence stage 1dosRassociated

-0.092

Amp0.2mg/mL AmpicillincellWall

-0.607

Cephalexin20-100 ug/mL CephalexincellWall

-0.424

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.434

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.451

EMB10-20 ug/mL EthambutolcellWall

-1.504

Eta12-40 ug/mL EthionamidecellWall

-1.155

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.662

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.217

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.236

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.321

BZA0.12 mg/mL BenzamidearomaticAmides

0.594

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.156

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.315

H2O24 mM hydrogen peroxideDNAdamaging

-0.446

Levo10 ug/mL LevofloxacinDNAdamaging

0.152

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.600

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.538

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.385

UVUV-irradiationDNAdamaging

0.441

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.049

Antimycin12.5-50 ug/mL Antimycin A?

0.343

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.558

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.261

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.928

PA8240.2-2 ug/mL PA-824?

0.514

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.020

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.106

Verapamil50 uM Verapamil?

1.347

mercaptoethanol2 mM 2-Mercaptoethanol?

0.170

methoxatin10-20 ug/mL Methoxatin?